Furong Lu

910 total citations
27 papers, 656 citations indexed

About

Furong Lu is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Furong Lu has authored 27 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Furong Lu's work include Adipose Tissue and Metabolism (4 papers), Natural product bioactivities and synthesis (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Furong Lu is often cited by papers focused on Adipose Tissue and Metabolism (4 papers), Natural product bioactivities and synthesis (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Furong Lu collaborates with scholars based in China and United States. Furong Lu's co-authors include You Qin, Xinghui Zhang, Yajun Li, Qin Zhang, Yun Wang, Lin Shen, Heng Li, Lan Gao, Wen Du and Mohammad Ishraq Zafar and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Experimental Cell Research.

In The Last Decade

Furong Lu

27 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Furong Lu China 14 197 117 109 86 71 27 656
Xiaoqin Yang China 16 293 1.5× 256 2.2× 29 0.3× 108 1.3× 51 0.7× 59 958
Aminuddin Aminuddin Indonesia 13 128 0.6× 39 0.3× 63 0.6× 77 0.9× 91 1.3× 129 821
Kyung Shin Paek South Korea 18 479 2.4× 50 0.4× 52 0.5× 19 0.2× 105 1.5× 42 931
Mohammad Reza Abedini Iran 13 295 1.5× 25 0.2× 57 0.5× 27 0.3× 55 0.8× 29 613
Liang Qiao China 19 619 3.1× 77 0.7× 40 0.4× 58 0.7× 46 0.6× 63 1.1k
Yue Dong China 16 245 1.2× 27 0.2× 181 1.7× 28 0.3× 23 0.3× 55 885
Jaqueline da Silva Brazil 16 166 0.8× 35 0.3× 104 1.0× 24 0.3× 42 0.6× 62 668
Ahmad Al‐Azayzih Jordan 17 288 1.5× 20 0.2× 39 0.4× 55 0.6× 21 0.3× 42 793
Xinhong Zhu China 12 104 0.5× 43 0.4× 70 0.6× 20 0.2× 17 0.2× 21 501
Tausif Ahmed Rajput Pakistan 9 63 0.3× 65 0.6× 144 1.3× 34 0.4× 12 0.2× 41 425

Countries citing papers authored by Furong Lu

Since Specialization
Citations

This map shows the geographic impact of Furong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Furong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Furong Lu more than expected).

Fields of papers citing papers by Furong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Furong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Furong Lu. The network helps show where Furong Lu may publish in the future.

Co-authorship network of co-authors of Furong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Furong Lu. A scholar is included among the top collaborators of Furong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Furong Lu. Furong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuting, et al.. (2025). Biomarkers of inflammation and colorectal cancer risk. Frontiers in Oncology. 15. 1514009–1514009. 3 indexed citations
2.
Qin, You, et al.. (2022). Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity. Frontiers in Immunology. 13. 881427–881427. 20 indexed citations
3.
Gan, Yong, et al.. (2022). Radiotherapy plus cetuximab or cisplatin in head and neck squamous cell carcinoma: an updated systematic review and meta-analysis of randomized controlled trials. European Archives of Oto-Rhino-Laryngology. 280(1). 11–22. 7 indexed citations
4.
Lu, Furong, et al.. (2021). Long noncoding RNAs: A potential target in sepsis-induced cellular disorder. Experimental Cell Research. 406(2). 112756–112756. 19 indexed citations
5.
He, Junbing, Tian Zhao, Furong Lu, et al.. (2021). The −172 A-to-G variation in ADAM17 gene promoter region affects EGR1/ADAM17 pathway and confers susceptibility to septic mortality with sepsis-3.0 criteria. International Immunopharmacology. 102. 108385–108385. 10 indexed citations
7.
Zhou, Cong, You Qin, Rui Chen, et al.. (2020). Fenugreek attenuates obesity-induced inflammation and improves insulin resistance through downregulation of iRhom2/TACE. Life Sciences. 378. 118222–118222. 15 indexed citations
8.
Shao, Yiming, Tian Zhao, Wenying Zhang, et al.. (2020). Presence of the apolipoprotein E-ε4 allele is associated with an increased risk of sepsis progression. Scientific Reports. 10(1). 15735–15735. 26 indexed citations
9.
Zhou, Cong, Rui Chen, Feng Gao, Jiaoyue Zhang, & Furong Lu. (2020). 4-Hydroxyisoleucine relieves inflammation through iRhom2-dependent pathway in co-cultured macrophages and adipocytes with LPS stimulation. BMC Complementary Medicine and Therapies. 20(1). 373–373. 6 indexed citations
10.
Zhou, Ying, et al.. (2017). Efficacy and Safety of Compound Kushen Injection on Patients with Advanced Colon Cancer: A Meta‐Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2017(1). 7102514–7102514. 37 indexed citations
12.
Du, Wen, et al.. (2015). 4-Hydroxyisoleucine ameliorates an insulin resistant-like state in 3T3-L1 adipocytes by regulating TACE/TIMP3 expression. Drug Design Development and Therapy. 9. 5727–5727. 22 indexed citations
14.
Zafar, Mohammad Ishraq, et al.. (2015). 4-Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF-α and regulating the expression of insulin signal transduction proteins. Molecular Medicine Reports. 12(5). 6555–6560. 28 indexed citations
15.
Shen, Lin, Yanping Yang, Furong Lu, et al.. (2013). Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis. Chinese Medical Journal. 126(13). 2480–2484. 18 indexed citations
16.
Qin, You, Chunyan Sun, Furong Lu, et al.. (2012). Cardamonin exerts potent activity against multiple myeloma through blockade of NF-κB pathway in vitro. Leukemia Research. 36(4). 514–520. 48 indexed citations
17.
Li, Jing, Lin Shen, Furong Lu, et al.. (2012). Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway. Acta Pharmacologica Sinica. 33(2). 242–249. 51 indexed citations
18.
19.
Lu, Furong, You Qin, & Lin Shen. (2010). Effect of Trigonella Foenum-graecum Saponin on Blood Glucose and Lipid Metabolism and Insulin Resistance in Diet-induced Obese Rats. Zhongguo zhongyiyao xinxi zazhi. 17(9). 34–36. 3 indexed citations
20.
Qin, You, Lin Shen, Furong Lu, Wei Shi, & Jianguo Liu. (2008). Effect of Xiaoyu Zhixue Tablet (消瘀止血片) on the expression of platelet membrane glycoprotein I b/IX/V complex in patients with chronic renal failure. Chinese Journal of Integrative Medicine. 14(2). 83–87. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026